(AP) — Option Care Health, Inc. (OPCH) on Wednesday reported third-quarter net income of $57.
Track this week’s biggest M&A deals across healthcare, energy, utilities, and tech—key buyouts, premiums, and valuations you need to know.
Analysts downgraded PJT, OPCH, CRBU, ABEV , cutting price targets for PJT, CRBU.
Option Care Health will be acquired by CD&R and McKesson for $32.05/share, valuing the company at $5.8 billion. Learn more about OPCH stock here.
Detailed price information for Mckesson Corp (MCK-N) from The Globe and Mail including charting and trades.
Detailed price information for Option Care Health Inc (OPCH-Q) from The Globe and Mail including charting and trades.
AMD, CEG, MRVL, OPCH, FCEL were among the stocks seen trending on Tuesday, Oct. 6, 2026.
Option Care Health Inc. (NASDAQ:OPCH) soared by as much as 33 percent on Tuesday to $31.11 apiece following news that it is merging with Clayson, Dubilier, & Rice LLC (CD&R) and McKesson Corp. for $5.8 billion. In a joint statement, the firms said that they entered into a definitive agreement under which they will acquire […]
Option Care Health agreed to a $5.8B buyout by CD&R and McKesson at $32.05 per share, pending shareholder and regulatory approvals.
The provider of home and alternate site infusion services is being acquired.
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares moved upwards by 52.5% to $7.0 during Tuesday's regular session. The company's market cap stands at $6.9 million. Option Care Health (NASDAQ:OPCH) stock
Option Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company.
Option Care Health has agreed to be acquired by CD&R and McKesson for $32. 05 per share in cash, representing approximately $5.
CD&R and McKesson acquire Option Care Health in a $5.8 billion transaction at $32.05 per share as analysts assess acquisition terms.
Option Care Health (OPCH) shares surged 34% after CD&R and McKesson (MCK) agreed to buy it for $32.05/share ($5.8B incl. debt).
McKesson Corp. and the private equity firm Clayton Dubilier & Rice will buy Option Care Health Inc. for an enterprise value of about $5.8 billion, expanding into the medical infusion space.
Oct 6 () - Drug distributor McKesson and private equity firm Clayton Dubilier & Rice on Tuesday agreed to buy infusion therapy provider Option Care Health in a deal worth about $5. The per-share offer price of $32.
Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-market session. The company's market cap stands at $2.4 million. Option Care Health (NASDAQ:OPCH) stock rose
NEW YORK & IRVING, Texas & BANNOCKBURN, Ill., October 06, 2026--CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (Nasdaq: OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the tran
These are the stocks posting the largest moves in early trading.
(Updates with the stock move in the headline and the second paragraph.) Option Care Health (OPCH)
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.
This is the newest page. Registered accounts read further back.